Skip to content

Depression: all studies

Page 14 of 1,034: studies 131 to 140 of 10,336, newest first. Back to the depression overview

Research

Ketamine improves ovarian function and oocyte quality in CORT-induced depression mouse model by ferroptosis pathway

Cell Death Discovery August 8, 2026 Yuqing Liu, Jiang Jiang, Yalong Wang et al.

Depression is a common psychiatric disorder, with a higher prevalence in women than in men, and has been increasingly associated with disturbances in female reproductive health. In particular, depressive conditions may impair ovarian function and compromise oocyte quality, thereby contributing to reproductive disorders. Ketamine is a clinically effective antidepressant. However, its potential...

Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial

Nature Medicine August 6, 2026 James Rucker, Tim Mantingh, Jess Kerr-Gaffney et al. 1 citation

Psilocybin-assisted therapy may be a promising new treatment for treatment-resistant depression. We examined the feasibility of administering a single 25-mg dose of psilocybin or placebo with psychological support in a randomized controlled trial design with 6 weeks of follow-up. A two-arm, double-blind, randomized, placebo-controlled feasibility trial was conducted at one National Health...

The protective association of mindfulness non-reactivity with depression among clinical nurses: a cross-sectional study

Frontiers in Psychiatry August 5, 2026 Zhi-Wen Gu, Xin Qin, Chang-Ping Yang et al.

Background Clinical nurses are essential to healthcare, but they experience high rates of depression, anxiety, and sleep disturbances. This study examined the relationships among occupational stressors, sleep problems, mindfulness, and psychological well-being in hospital nurses. Methods In a cross-sectional study of 416 clinical nurses from a tertiary general hospital in China, we assessed...

The molecular and neurochemical basis of altered intrinsic neural timescales in major depressive disorder: a multimodal imaging-transcriptomic investigation of esketamine and sertraline treatment

BMC Psychiatry August 5, 2026 Xiang Liu, Yuanzhi He, Lifeng Li et al.

Abstract Introduction Major depressive disorder (MDD) is characterized by dysfunction in higher-order cortical regions involved in emotional and cognitive processes; however, its neurobiological basis remains unclear. Pharmacological treatments, including esketamine and sertraline, produce rapid antidepressant effects. We investigated the local intrinsic neural dynamics underlying these...

Effects of Remotely Delivered and Web-Based Interventions on Depression Severity During the COVID-19 Pandemic: 3-Arm Randomized Controlled Trial.

JMIR Mental Health August 4, 2026 Zev Schuman-Olivier, Liv Valö, Joseph Rosansky et al.

The COVID-19 pandemic highlighted a critical need for effective population mental health approaches to target the most prevalent disorders (eg, depression) during periods of elevated community distress. The effectiveness of remotely delivered and web-based interventions should be investigated to identify and innovate high-quality models for population mental health service delivery. The primary...

DOI: 10.2196/88388 (opens in new tab) Full text (opens in new tab) Depression Covid-19 pandemic Mindfulness-based cognitive therapy Cognitive behavioral therapy +5

Resisting Racial Microaggressions: Assessing the Moderated-Mediation Effects of Racial Microaggressions, Mindfulness Traits, Depression, and Purpose in Life

Journal of Prevention and Health Promotion August 4, 2026 Aldo M Barrita, Oswaldo A. Moreno, Natalia Gomez Giuliani et al.

This study examined the psychological impact of racial microaggressions among racially minoritized young adults. Specifically, the study tested the direct and indirect effects of racial microaggressions on purpose of life through depressive symptoms, while also considering the buffering effects of mindfulness practices on the relationships between these variables. Using a cross-sectional...

New treatments for treatment-resistant depression: esketamine controversies - a narrative review.

Danish medical journal August 4, 2026 Maj Vinberg

This narrative review examines barriers to Danish patients' timely access to new treatments for treatment-resistant depression, focusing on controversies around esketamine. Delays arise from regulatory complexity, economic constraints and scientific debate over novel psychotropics. The review advocates evidence-based, faster implementation pathways for new treatments to alleviate the overall...

Virtual reality mindfulness-based cognitive therapy for reducing psychological distress in people with depression and/or anxiety symptoms: two uncontrolled feasibility studies

Pilot and Feasibility Studies August 4, 2026 Rebecca L. Gould, Matthew Hoad-Robson, Kim Bevan et al.

Abstract Background Group mindfulness-based cognitive therapy (MBCT) is recommended for the treatment of subthreshold-to-mild depressive symptoms. Timely access to MBCT, however, is limited by accessibility issues. Self-help MBCT can overcome these issues, but is associated with poorer engagement. Incorporating virtual reality into self-help MBCT (VR-MBCT) may improve engagement, but relatively...

Mindfulness-based interventions for perinatal depression, anxiety, and stress: a systematic review and meta-analysis of randomized controlled trials, with an exploratory subgroup signal by delivery mode

Frontiers in Psychiatry August 4, 2026 Gaoqin Tang, Unfai Cho, Jun Zhang et al.

Background: Perinatal depression is a highly common clinical complication. While expert panels advocate for non-pharmacological treatments, the relative benefits of mindfulness-based interventions delivered face-to-face versus through emerging digital platforms have not been examined within a single integrated synthesis that distinguishes the contribution of delivery mode from that of trial era...

Evaluating psilocybin for the management of depression: a literature review

British Journal of Mental Health Nursing August 2, 2026 Rachel Sinclair

Depression remains a significant public health concern worldwide and many individuals do not achieve adequate symptom relief from conventional treatments such as antidepressants and psychological therapies. Interest has therefore increased in alternative interventions, including psilocybin microdosing. This article aimed to critically review the current evidence regarding the use of psilocybin...